238 related articles for article (PubMed ID: 32756554)
1. Serum discrimination and phenotype assessment of coronary artery disease patents with and without type 2 diabetes prior to coronary artery bypass graft surgery.
Hocker JR; Lerner M; Lightfoot SA; Peyton MD; Thompson JL; Deb S; Reinersman M; Hanas RJ; Postier RG; Edil BH; Burkhart HM; Hanas JS
PLoS One; 2020; 15(8):e0234539. PubMed ID: 32756554
[TBL] [Abstract][Full Text] [Related]
2. Serum protein signature of coronary artery disease in type 2 diabetes mellitus.
Adela R; Reddy PNC; Ghosh TS; Aggarwal S; Yadav AK; Das B; Banerjee SK
J Transl Med; 2019 Jan; 17(1):17. PubMed ID: 30674322
[TBL] [Abstract][Full Text] [Related]
3. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.
Sprandel MC; Hueb WA; Segre A; Ramires JA; Kalil-Filho R; Maranhão RC
Cardiovasc Diabetol; 2015 Aug; 14():107. PubMed ID: 26268997
[TBL] [Abstract][Full Text] [Related]
4. The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL; Larsen SB; Phoenix F; Kurdee Z; Grant PJ; Ajjan RA
Thromb Haemost; 2014 Dec; 112(6):1142-50. PubMed ID: 25187394
[TBL] [Abstract][Full Text] [Related]
5. Serum CXCL16 as a Novel Biomarker of Coronary Artery Disease in Type 2 Diabetes Mellitus: a Pilot Study.
Zhou F; Wang J; Wang K; Zhu X; Pang R; Li X; Zhu G; Pan X
Ann Clin Lab Sci; 2016; 46(2):184-9. PubMed ID: 27098626
[TBL] [Abstract][Full Text] [Related]
6. Revascularisation of type 2 diabetics with coronary artery disease: Insights and therapeutic targeting of O-GlcNAcylation.
Bolanle IO; Riches-Suman K; Loubani M; Williamson R; Palmer TM
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1349-1356. PubMed ID: 33812732
[TBL] [Abstract][Full Text] [Related]
7. Butyrylcholinesterase K variant and the APOE-epsilon 4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients.
Vaisi-Raygani A; Rahimi Z; Tavilani H; Pourmotabbed T
Mol Biol Rep; 2010 Apr; 37(4):2083-91. PubMed ID: 19685167
[TBL] [Abstract][Full Text] [Related]
8. Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.
Qamar A; Khetarpal SA; Khera AV; Qasim A; Rader DJ; Reilly MP
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1880-8. PubMed ID: 26069232
[TBL] [Abstract][Full Text] [Related]
9. Serum S100A12 levels are correlated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
Zhao P; Wu M; Yu H; Huang Y; Wang Y; Wang W; Yin W
J Investig Med; 2013 Jun; 61(5):861-6. PubMed ID: 23609464
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of MSH2, XRCC1 and ATM genes in patients with type 2 diabetes and coronary artery disease.
Ahmadi A; Behmanesh M; Boroumand MA; Tavallaei M
Diabetes Res Clin Pract; 2015 Sep; 109(3):500-6. PubMed ID: 26088318
[TBL] [Abstract][Full Text] [Related]
11. Association of C1q/TNF-Related Protein-3 (CTRP3) and CTRP13 Serum Levels with Coronary Artery Disease in Subjects with and without Type 2 Diabetes Mellitus.
Fadaei R; Moradi N; Baratchian M; Aghajani H; Malek M; Fazaeli AA; Fallah S
PLoS One; 2016; 11(12):e0168773. PubMed ID: 28033351
[TBL] [Abstract][Full Text] [Related]
12. Novel Biomarkers for Coronary Restenosis Occurrence After Drug-Eluting Stent Implantation in Patients With Diabetes Having Stable Coronary Artery Disease.
Gabbasov Z; Kozlov S; Melnikov I; Byazrova S; Saburova O; Prokofieva L; Caprnda M; Curilla E; Gaspar L; Rodrigo L; Kruzliak P; Smirnov V
Clin Appl Thromb Hemost; 2018 Nov; 24(8):1308-1314. PubMed ID: 29716394
[TBL] [Abstract][Full Text] [Related]
13. Association between vaspin level and coronary artery disease in patients with type 2 diabetes.
Hao F; Zhang H; Zhu J; Kuang H; Yu Q; Bai M; Mu J
Diabetes Res Clin Pract; 2016 Mar; 113():26-32. PubMed ID: 26972957
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell activation is blunted in patients with coronary artery disease and diabetes mellitus.
Yetkin GI; Yucel AA; Tekin İÖ; Yılmaz M; Atalay H; Yetkin E
J Diabetes Complications; 2019 Feb; 33(2):134-139. PubMed ID: 30522792
[TBL] [Abstract][Full Text] [Related]
15. Impaired red blood cell deformability in patients with coronary artery disease and diabetes mellitus.
Keymel S; Heiss C; Kleinbongard P; Kelm M; Lauer T
Horm Metab Res; 2011 Oct; 43(11):760-5. PubMed ID: 22009370
[TBL] [Abstract][Full Text] [Related]
16. Coronary heart disease risk equivalence in diabetes and arterial diseases characterized by endothelial function and endothelial progenitor cell.
Liao YF; Feng Y; Chen LL; Zeng TS; Yu F; Hu LJ
J Diabetes Complications; 2014; 28(2):214-8. PubMed ID: 24332936
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein (a) is not significantly associated with type 2 diabetes mellitus: cross-sectional study of 1604 cases and 7983 controls.
Liu C; Xu MX; He YM; Zhao X; Du XJ; Yang XJ
Acta Diabetol; 2017 May; 54(5):443-453. PubMed ID: 28132096
[TBL] [Abstract][Full Text] [Related]
18. Serum resistin as a biological marker for coronary artery disease and restenosis in type 2 diabetic patients.
On YK; Park HK; Hyon MS; Jeon ES
Circ J; 2007 Jun; 71(6):868-73. PubMed ID: 17526982
[TBL] [Abstract][Full Text] [Related]
19. High serum interleukin-18 concentrations in patients with coronary artery disease and type 2 diabetes mellitus.
Suchanek H; Myśliwska J; Siebert J; Wieckiewicz J; Hak Ł; Szyndler K; Kartanowicz D
Eur Cytokine Netw; 2005 Sep; 16(3):177-85. PubMed ID: 16266856
[TBL] [Abstract][Full Text] [Related]
20. Fractalkine and its receptor (CX3CR1) in patients with stable coronary artery disease and diabetes mellitus.
Njerve IU; Pettersen AÅ; Opstad TB; Arnesen H; Seljeflot I
Metab Syndr Relat Disord; 2012 Dec; 10(6):400-6. PubMed ID: 22897138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
